Milind Javle
MD
Professor of Gastrointestinal Medical Oncology
👥Biography 个人简介
Milind Javle is a leader in biliary tract cancer clinical trials and FGFR targeted therapy. He led pivotal studies of pemigatinib and other FGFR inhibitors in cholangiocarcinoma. His work helped establish the first FDA approved targeted therapies for this disease. He is among the most cited experts in hepatobiliary oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Milind Javle 的研究动态
Follow Milind Javle's research updates
留下邮箱，当我们发布与 Milind Javle（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment